mhurhangee/ep-ind-claims huggingface dataset:
A fuel cell comprising: a plurality of fuel cell boards (22, 400), each fuel cell board (22, 400) comprising at least one ion permeable membrane, at least one anode and at least one cathode, the at least one anode and the at least one cathode arranged on opposite surfaces of the at least one ion permeable membrane, wherein the plurality of fuel cell boards (22, 400) are arranged such that the first surface of each fuel cell board (22, 400) faces the first surface of an adjacent fuel cell board (22, 400), and the second surface of each fuel cell board (22, 400) faces the second surface of an adjacent fuel cell board (22, 400); and a plurality of fluid paths arranged to supply a coolant fluid to the plurality of fuel cell boards (22, 400), wherein the plurality of fluid paths are arranged between the first surfaces of an adjacent fuel cell boards (22, 400) such that the coolant fluid is substantially directed only to the at least one anode of the fuel cell boards (22, 400); a plurality of second fluid paths arranged to supply a reactant fluid to the plurality of fuel cell boards (22, 400), wherein the plurality of second fluid paths are arranged between the second surfaces of adjacent fuel cell boards (22, 400) such that the reactant fluid is substantially directed only to at least one cathode of the fuel cell boards (22, 400), wherein the coolant fluid is air. a plurality of fuel cell boards (22, 400), each fuel cell board (22, 400) comprising at least one ion permeable membrane, at least one anode and at least one cathode, the at least one anode and the at least one cathode arranged on opposite surfaces of the at least one ion permeable membrane, wherein the plurality of fuel cell boards (22, 400) are arranged such that the first surface of each fuel cell board (22, 400) faces the first surface of an adjacent fuel cell board (22, 400), and the second surface of each fuel cell board (22, 400) faces the second surface of an adjacent fuel cell board (22, 400); and a plurality of fluid paths arranged to supply a coolant fluid to the plurality of fuel cell boards (22, 400), wherein the plurality of fluid paths are arranged between the first surfaces of an adjacent fuel cell boards (22, 400) such that the coolant fluid is substantially directed only to the at least one anode of the fuel cell boards (22, 400); a plurality of second fluid paths arranged to supply a reactant fluid to the plurality of fuel cell boards (22, 400), wherein the plurality of second fluid paths are arranged between the second surfaces of adjacent fuel cell boards (22, 400) such that the reactant fluid is substantially directed only to at least one cathode of the fuel cell boards (22, 400), wherein the coolant fluid is air.
A pharmaceutical composition for use in protection of a subject's gastrointestinal microbiome from a beta-lactam oral antibiotic, comprising a beta-lactamase that is capable of deactivating the beta-lactam oral antibiotic, wherein the subject is undergoing treatment or has recently undergone treatment with the beta-lactam oral antibiotic, wherein: the pharmaceutical composition comprises an enterically coated capsule comprising an enterically coated pellet, the pellet comprising, relative to a pellet's weight: about 20% to 25% sucrose sphere; about 30% to 40% binder excipient; about 12% to 18% beta-lactamase; about 1% to 2% buffer salts; about 0.5% to 3% plasticizer; about 15% to 30% polymethacrylate-based copolymer (EUDRAGIT) coating, optionally wherein the the EUDRAGIT coating is selected from EUDRAGIT FS 30 D and EUDRAGIT S100, and optionally about 0.5% to about 1.5% KH 2 PO 4 and about 2.5% to 5% HPMC 603; and the capsule is coated with EUDRAGIT FS 30 D; wherein EUDRAGIT FS 30 D refers to an aqueous dispersion of an anionic random copolymer based on methyl acrylate, methyl methacrylate and methacrylic acid, in which the ratio of the free carboxyl groups to the ester groups is approx. 1:10 and having a M w of approx. 280,000 g/mol; and wherein EUDRAGIT S100 is a random anionic copolymer based on methacrylic acid and methyl methacrylate, in which the ratio of the free carboxyl groups to the ester groups is approx. 1:2 and having a Mw of approx. 125,000 g/mol. the pharmaceutical composition comprises an enterically coated capsule comprising an enterically coated pellet, the pellet comprising, relative to a pellet's weight: about 20% to 25% sucrose sphere; about 30% to 40% binder excipient; about 12% to 18% beta-lactamase; about 1% to 2% buffer salts; about 0.5% to 3% plasticizer; about 15% to 30% polymethacrylate-based copolymer (EUDRAGIT) coating, optionally wherein the the EUDRAGIT coating is selected from EUDRAGIT FS 30 D and EUDRAGIT S100, and optionally about 0.5% to about 1.5% KH 2 PO 4 and about 2.5% to 5% HPMC 603; and about 20% to 25% sucrose sphere; about 30% to 40% binder excipient; about 12% to 18% beta-lactamase; about 1% to 2% buffer salts; about 0.5% to 3% plasticizer; about 15% to 30% polymethacrylate-based copolymer (EUDRAGIT) coating, optionally wherein the the EUDRAGIT coating is selected from EUDRAGIT FS 30 D and EUDRAGIT S100, and optionally about 0.5% to about 1.5% KH 2 PO 4 and about 2.5% to 5% HPMC 603; and the capsule is coated with EUDRAGIT FS 30 D; wherein EUDRAGIT FS 30 D refers to an aqueous dispersion of an anionic random copolymer based on methyl acrylate, methyl methacrylate and methacrylic acid, in which the ratio of the free carboxyl groups to the ester groups is approx. 1:10 and having a M w of approx. 280,000 g/mol; and wherein EUDRAGIT S100 is a random anionic copolymer based on methacrylic acid and methyl methacrylate, in which the ratio of the free carboxyl groups to the ester groups is approx. 1:2 and having a Mw of approx. 125,000 g/mol.
An ultrasound probe, comprising: a housing configured for handheld operation by a user; a transducer array coupled to the housing and configured to obtain ultrasound data; a cable coupled to the housing, wherein the cable comprises a conduit and a plurality of electrical conductors in communication with the transducer array, wherein the plurality of electrical conductors comprises a distal portion disposed within the housing and a proximal portion disposed within the conduit; and an elastomeric insert (232, 332, 432, 532, 632, 732, 832) disposed within the housing and comprising a compressed state and an uncompressed state, wherein the elastomeric insert is in contact with the plurality of electrical conductors such that application of a force on the cable causes the plurality of electrical conductors to compress the elastomeric insert into the compressed state and such that, upon cessation of the force on the cable, the elastomeric insert moves the plurality of electrical conductors while returning to the uncompressed state, wherein the distal portion of the plurality of electrical conductors is arranged into a first bundle and a second bundle, and the first bundle is disposed on a first side of the elastomeric insert and the second bundle is disposed on an opposite, second side of the elastomeric insert. a housing configured for handheld operation by a user; a transducer array coupled to the housing and configured to obtain ultrasound data; a cable coupled to the housing, wherein the cable comprises a conduit and a plurality of electrical conductors in communication with the transducer array, wherein the plurality of electrical conductors comprises a distal portion disposed within the housing and a proximal portion disposed within the conduit; and an elastomeric insert (232, 332, 432, 532, 632, 732, 832) disposed within the housing and comprising a compressed state and an uncompressed state, wherein the elastomeric insert is in contact with the plurality of electrical conductors such that application of a force on the cable causes the plurality of electrical conductors to compress the elastomeric insert into the compressed state and such that, upon cessation of the force on the cable, the elastomeric insert moves the plurality of electrical conductors while returning to the uncompressed state, wherein the distal portion of the plurality of electrical conductors is arranged into a first bundle and a second bundle, and the first bundle is disposed on a first side of the elastomeric insert and the second bundle is disposed on an opposite, second side of the elastomeric insert.
Mixture for use as binder in the no-bake process, comprising (a) monomeric furfuryl alcohol, wherein the amount of monomeric furfuryl alcohol is at most 25 wt.%, (b) 40 wt.% or more of reaction products of formaldehyde, wherein the reaction products comprise (b-1) reaction products of formaldehyde with furfuryl alcohol and optionally other constituents, and (b-2) optionally reaction products of formaldehyde with one or a plurality of other compounds, which is not or are not furfuryl alcohol, (c) water, wherein the amount of water is at most 20 wt.%, (d) one or a plurality of organic acids with a pKa value greater than or equal to 2.5, preferably in the range from 2.75 to 6, preferably in the range from 3 to 5, at 25°C and/or salts thereof, (e) one or a plurality of adhesion promoters, preferably selected from the group of silanes, preferably N-aminopropylmethyldiethoxysilane, N-aminoethyl-3-aminopropyltrimethoxysilane, N-aminoethyl-3-aminopropylmethyldiethoxysilane and/or N-aminopropyltriethoxysilane, in a total amount from 0.1 to 3 wt.%, wherein the mixture has a content of free formaldehyde of at most 0.5 wt.%, wherein the percentages by weight are relative to the total weight of the mixture. (a) monomeric furfuryl alcohol, wherein the amount of monomeric furfuryl alcohol is at most 25 wt.%, (b) 40 wt.% or more of reaction products of formaldehyde, wherein the reaction products comprise (b-1) reaction products of formaldehyde with furfuryl alcohol and optionally other constituents, and (b-2) optionally reaction products of formaldehyde with one or a plurality of other compounds, which is not or are not furfuryl alcohol, (b-1) reaction products of formaldehyde with furfuryl alcohol and optionally other constituents, and (b-2) optionally reaction products of formaldehyde with one or a plurality of other compounds, which is not or are not furfuryl alcohol, (c) water, wherein the amount of water is at most 20 wt.%, (d) one or a plurality of organic acids with a pKa value greater than or equal to 2.5, preferably in the range from 2.75 to 6, preferably in the range from 3 to 5, at 25°C and/or salts thereof, (e) one or a plurality of adhesion promoters, preferably selected from the group of silanes, preferably N-aminopropylmethyldiethoxysilane, N-aminoethyl-3-aminopropyltrimethoxysilane, N-aminoethyl-3-aminopropylmethyldiethoxysilane and/or N-aminopropyltriethoxysilane, in a total amount from 0.1 to 3 wt.%,
An evolved NodeB, eNB, (160, 1260, 1460) comprising: a processor; and memory in electronic communication with the processor, wherein instructions stored in the memory are executable to: perform a channel sensing on a Licensed-Assisted Access, LAA, secondary cell, SCell, for a transmission; manage a counter based on whether or not the channel is sensed to be idle; determine if the channel is sensed to be idle and the counter reaches zero, whether or not the eNB performs the transmission; and (i) in a case where it is determined that the eNB performs the transmission, perform the transmission and (ii) in a case where it is determined that the eNB does not perform the transmission, defer the transmission and perform an additional channel sensing for the transmission. a processor; and memory in electronic communication with the processor, wherein instructions stored in the memory are executable to: perform a channel sensing on a Licensed-Assisted Access, LAA, secondary cell, SCell, for a transmission; manage a counter based on whether or not the channel is sensed to be idle; determine if the channel is sensed to be idle and the counter reaches zero, whether or not the eNB performs the transmission; and (i) in a case where it is determined that the eNB performs the transmission, perform the transmission and (ii) in a case where it is determined that the eNB does not perform the transmission, defer the transmission and perform an additional channel sensing for the transmission. perform a channel sensing on a Licensed-Assisted Access, LAA, secondary cell, SCell, for a transmission; manage a counter based on whether or not the channel is sensed to be idle; determine if the channel is sensed to be idle and the counter reaches zero, whether or not the eNB performs the transmission; and (i) in a case where it is determined that the eNB performs the transmission, perform the transmission and (ii) in a case where it is determined that the eNB does not perform the transmission, defer the transmission and perform an additional channel sensing for the transmission. (i) in a case where it is determined that the eNB performs the transmission, perform the transmission and (ii) in a case where it is determined that the eNB does not perform the transmission, defer the transmission and perform an additional channel sensing for the transmission.
A hood for a convertible vehicle, which can be displaced between a position at least partly covering a passenger compartment and a position at least partly exposing the passenger compartment, and which has a rear roof element which can be moved at least partly independently of other roof elements (11 to 25) and which can be displaced between a closed position when the hood is in the closed position and a position moved at least partly upwards with respect to the closed position, wherein the rear roof element is mounted on its side towards the hood front on a hood linkage, and wherein a separate lever mechanism is provided for displacing the rear roof element between its closed position and its upwardly moved position, by means of which lever mechanism the rear roof element can be fixed directly to the vehicle body, characterised in that the lever mechanism is designed as a toggle lever mechanism with two levers (37, 39) and is designed to hold the rear roof element in its closed position, the lever mechanism having no direct connection to the hood linkage provided for moving the roof parts covering the passenger compartment between their closed and open positions, and the lever mechanism being connected only to the rear roof element and being able to be fixed to the vehicle body.
Field sprayer with a distribution manifold and a plurality of nozzle assemblies attached thereto, each comprising a nozzle holder with a valve for the pulse-width-modulated release of a spray and adjoining this a spray duct and at least one connection for a spray nozzle, wherein a cavity for inserting a spray filter is formed in the connection, wherein the nozzle assemblies each comprise a reducing piece which is present in the cavity instead of the spray filter and which has a line cross-section which is reduced in comparison with to the cavity, characterized in that in each case the line cross-section of the reducing piece, in particular on average, is 5-50 mm 2 and in particular 10-30 mm 2 and wherein the reducing piece in each case has an external volume that is at least 50%, in particular at least 75%, of the volume of the cavity.
A method for controlling access comprising: writing information on a card in a two-dimensional code, the information including information about a card holder and a description of a movement needed for access, the movement including moving the card in at least one rotation and/or direction; scanning the card with a card scanner while performing a gesture with the card, the card scanner reading the information from the two-dimensional code on the card and recognizing the gesture; comparing the read information about a card holder with information about a card holder contained in the card scanner and the recognized gesture with the rotation and/or direction information contained in the two-dimensional code on the card; and wherein when the information about the card holder matches information about a card holder contained in the card scanner and the performed gesture matches the description of the movement contained in the two-dimensional code, access is granted. writing information on a card in a two-dimensional code, the information including information about a card holder and a description of a movement needed for access, the movement including moving the card in at least one rotation and/or direction; scanning the card with a card scanner while performing a gesture with the card, the card scanner reading the information from the two-dimensional code on the card and recognizing the gesture; comparing the read information about a card holder with information about a card holder contained in the card scanner and the recognized gesture with the rotation and/or direction information contained in the two-dimensional code on the card; and wherein when the information about the card holder matches information about a card holder contained in the card scanner and the performed gesture matches the description of the movement contained in the two-dimensional code, access is granted.
A compound of the following formula, wherein, R 1 is selected from methyl or ethyl, preferably methyl; R 4 is selected from hydrogen or methyl, preferably methyl; n is 1-4, preferably 1; X is F, Cl or CF 3, preferably F. R 1 is selected from methyl or ethyl, preferably methyl; R 4 is selected from hydrogen or methyl, preferably methyl; n is 1-4, preferably 1; X is F, Cl or CF 3, preferably F.
A method for treating liquefied hydrocarbons comprising acid gases to remove said acid gases while minimizing loss of amine species, said method comprising the step of contacting said liquefied hydrocarbons with an absorbent aqueous solution of a first amine compound, said first amine compound having the structure wherein R1 is hydrogen, propane-2,3-diol, and mixtures thereof and R2 is propane-2,3-diol.
Deodorizing and sanitizing apparatus, comprising: structure defining an enclosed treatment zone operable to hold an item of clothing for treatment, said zone-defining structure comprising a housing that includes a lower wall; an ozone generator; and a ventilation assembly operable to create currents of air containing ozone from said generator, and to pass such ozone-laden air currents in proximity to said item for a period of time sufficient to deodorize and sanitize the item; characterized in that said apparatus further comprises a base including a bottom wall, continuously extending a sidewall, and an internal compartment, said compartment being defined by upright walls (40,42) projecting from the bottom wall of the base, said upright walls (40,42) being spaced laterally inward from the sidewall, such that the internal compartment is spaced from the sidewall; and wherein said ozone generator is positioned below the lower wall within the compartment, such that the generator is outside the treatment zone and housed within the compartment. structure defining an enclosed treatment zone operable to hold an item of clothing for treatment, said zone-defining structure comprising a housing that includes a lower wall; an ozone generator; and a ventilation assembly operable to create currents of air containing ozone from said generator, and to pass such ozone-laden air currents in proximity to said item for a period of time sufficient to deodorize and sanitize the item; characterized in that said apparatus further comprises a base including a bottom wall, continuously extending a sidewall, and an internal compartment, said compartment being defined by upright walls (40,42) projecting from the bottom wall of the base, said upright walls (40,42) being spaced laterally inward from the sidewall, such that the internal compartment is spaced from the sidewall; and wherein said ozone generator is positioned below the lower wall within the compartment, such that the generator is outside the treatment zone and housed within the compartment.
An air conditioning device for a vehicle, with a circuit of refrigerant fluid, including at least: - a compression member for circulating the refrigerant fluid and for pressurizing the fluid in the circuit; - a condensation member permitting the transfer of refrigerant fluid from a gaseous phase into a liquid phase; the air conditioning device being characterized by an on-board estimator of the power of a compression member, which is able to calculate the power consumed by the compression member by a high thermodynamic balance on the condensation member as a function of the mass flow of air and of the mass flow of refrigerant fluid passing through the condensation member, and in that the estimator is able to calculate the power of two modes, depending on a status of a clutch which connects the compression member to the shaft of the engine or to the engine of the vehicle. - a compression member for circulating the refrigerant fluid and for pressurizing the fluid in the circuit; - a condensation member permitting the transfer of refrigerant fluid from a gaseous phase into a liquid phase; the air conditioning device being characterized by an on-board estimator of the power of a compression member, which is able to calculate the power consumed by the compression member by a high thermodynamic balance on the condensation member as a function of the mass flow of air and of the mass flow of refrigerant fluid passing through the condensation member, and in that the estimator is able to calculate the power of two modes, depending on a status of a clutch which connects the compression member to the shaft of the engine or to the engine of the vehicle.
A method for a fully contained closed loop sterility test using a cell-capturing and cell-culturing device, wherein the method includes the steps of filtration of a sample through a membrane of the device, addition of nutrient media to support cell growth, and imaging of the device, without exposing the sample or other internal components to possible outside contaminants.
An isolated antigen-binding molecule, which is capable of binding to HER3, wherein the antigen-binding molecule comprises: (i) a heavy chain variable region incorporating the following CDRs: HC-CDR1 having the amino acid sequence of SEQ ID NO:41 HC-CDR2 having the amino acid sequence of SEQ ID NO:45 HC-CDR3 having the amino acid sequence of SEQ ID NO:48; and (ii) a light chain variable region incorporating the following CDRs: LC-CDR1 having the amino acid sequence of SEQ ID NO:88 LC-CDR2 having the amino acid sequence of SEQ ID NO:92 LC-CDR3 having the amino acid sequence of SEQ ID NO:95. (i) a heavy chain variable region incorporating the following CDRs: HC-CDR1 having the amino acid sequence of SEQ ID NO:41 HC-CDR2 having the amino acid sequence of SEQ ID NO:45 HC-CDR3 having the amino acid sequence of SEQ ID NO:48; and HC-CDR1 having the amino acid sequence of SEQ ID NO:41 HC-CDR2 having the amino acid sequence of SEQ ID NO:45 HC-CDR3 having the amino acid sequence of SEQ ID NO:48; and (ii) a light chain variable region incorporating the following CDRs: LC-CDR1 having the amino acid sequence of SEQ ID NO:88 LC-CDR2 having the amino acid sequence of SEQ ID NO:92 LC-CDR3 having the amino acid sequence of SEQ ID NO:95. LC-CDR1 having the amino acid sequence of SEQ ID NO:88 LC-CDR2 having the amino acid sequence of SEQ ID NO:92 LC-CDR3 having the amino acid sequence of SEQ ID NO:95.